Literature DB >> 18727699

Association between primary graft dysfunction among lung, kidney and heart recipients from the same multiorgan donor.

T Oto1, L Excell, A P Griffiths, B J Levvey, M Bailey, S Marasco, P Macdonald, G I Snell.   

Abstract

Even organs from an ideal donor will occasionally develop primary graft dysfunction (PGD) causing a significant morbidity and mortality after transplantation. It is likely that this situation represents subtle undetectable levels of ongoing donor organ dysfunction. The aim of this study is to investigate the association of PGD between lung, kidney and heart recipients from the one donor. From 202 multiorgan donors, contributed 231 consecutive lung transplants at the Alfred Hospital, 378 kidney and 114 heart transplants were subsequently performed at multiple centers across Australia and New Zealand. Eight hundred seventy-five organs were used for 723 transplants. The incidence of PGD after lung, kidney and heart transplants was 20% (47/231), 24% (92/378) and 20% (23/114), respectively. In paired single organ recipients, PGD in one of the pair was a significant risk factor for the development of PGD in the other [lung: odds ratio = 5.63 (1.72-18.43), p = 0.004; kidney: odds ratio = 3.19 (1.90-5.35), p < 0.0001]. In multivariate analysis, same donor heart PGD [3.37 (1.19-9.50), p = 0.02] was an independent risk factor for lung PGD and same donor lung PGD was significant risk factor for kidney PGD [1.94 (1.01-3.73), p = 0.04], if the PGD status of the paired kidney was not known. There was a significant association for the development of PGD across different organs transplanted from the same donor.

Entities:  

Mesh:

Year:  2008        PMID: 18727699     DOI: 10.1111/j.1600-6143.2008.02357.x

Source DB:  PubMed          Journal:  Am J Transplant        ISSN: 1600-6135            Impact factor:   8.086


  9 in total

Review 1.  Lung transplantation from donation after cardiac death (non-heart-beating) donors.

Authors:  Takahiro Oto
Journal:  Gen Thorac Cardiovasc Surg       Date:  2008-11-12

2.  Natural killer cells activated through NKG2D mediate lung ischemia-reperfusion injury.

Authors:  Daniel R Calabrese; Emily Aminian; Benat Mallavia; Fengchun Liu; Simon J Cleary; Oscar A Aguilar; Ping Wang; Jonathan P Singer; Steven R Hays; Jeffrey A Golden; Jasleen Kukreja; Daniel Dugger; Mary Nakamura; Lewis L Lanier; Mark R Looney; John R Greenland
Journal:  J Clin Invest       Date:  2021-02-01       Impact factor: 14.808

3.  Primary graft failure after heart transplantation.

Authors:  Arjun Iyer; Gayathri Kumarasinghe; Mark Hicks; Alasdair Watson; Ling Gao; Aoife Doyle; Anne Keogh; Eugene Kotlyar; Christopher Hayward; Kumud Dhital; Emily Granger; Paul Jansz; Roger Pye; Phillip Spratt; Peter Simon Macdonald
Journal:  J Transplant       Date:  2011-08-01

4.  The role of donor chronic alcohol abuse in the development of primary graft dysfunction in lung transplant recipients.

Authors:  Andres Pelaez; Patrick O Mitchell; Nimesh S Shah; Seth D Force; Lisa Elon; Lou Ann S Brown; David M Guidot
Journal:  Am J Med Sci       Date:  2015-02       Impact factor: 2.378

Review 5.  Brain death and care of the organ donor.

Authors:  Lakshmi Kumar
Journal:  J Anaesthesiol Clin Pharmacol       Date:  2016 Apr-Jun

6.  Brain death-induced cytokine release is not associated with primary graft dysfunction: a cohort study.

Authors:  Tatiana Helena Rech; Geisiane Custódio; Leonardo Viliano Kroth; Sabrina Frighetto Henrich; Édison Moraes Rodrigues Filho; Daisy Crispim; Cristiane Bauermann Leitão
Journal:  Rev Bras Ter Intensiva       Date:  2019-03-21

Review 7.  Primary graft dysfunction after heart transplantation: a thorn amongst the roses.

Authors:  Sanjeet Singh Avtaar Singh; Jonathan R Dalzell; Colin Berry; Nawwar Al-Attar
Journal:  Heart Fail Rev       Date:  2019-09       Impact factor: 4.214

8.  Deceased organ donation for transplantation: Challenges and opportunities.

Authors:  Raffaele Girlanda
Journal:  World J Transplant       Date:  2016-09-24

9.  Substantial Increases Occur in Serum Activins and Follistatin during Lung Transplantation.

Authors:  David M de Kretser; Jonathan G Bensley; David J Phillips; Bronwyn J Levvey; Greg I Snell; Enjarn Lin; Mark P Hedger; Robyn E O'Hehir
Journal:  PLoS One       Date:  2016-01-28       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.